Alzheimer Disease Detection Studies: Perspective on Multi-Modal Data

阿尔茨海默病检测研究:多模态数据视角

阅读:1

Abstract

OBJECTIVES: Alzheimer's Disease (AD) is one of the most common neurodegenerative diseases, resulting in progressive cognitive decline, and so accurate and timely AD diagnosis is of critical importance. To this end, various medical technologies and computer-aided diagnosis (CAD), ranging from biosensors and raw signals to medical imaging, have been used to provide information about the state of AD. In this survey, we aim to provide a review on CAD systems for automated AD detection, focusing on different data types: namely, signals and sensors, medical imaging, and electronic medical records (EMR). METHODS: We explored the literature on automated AD detection from 2022-2023. Specifically, we focused on various data resources and reviewed several preprocessing and learning methodologies applied to each data type, as well as evaluation metrics for model performance evaluation. Further, we focused on challenges, future perspectives, and recommendations regarding automated AD diagnosis. RESULTS: Compared to other modalities, medical imaging was the most common data type. The prominent modality was Magnetic Resonance Imaging (MRI). In contrast, studies based on EMR data type were marginal because EMR is mostly used for AD prediction rather than detection. Several challenges were identified: data scarcity and bias, imbalanced datasets, missing information, anonymization, lack of standardization, and explainability. CONCLUSION: Despite recent developments in automated AD detection, improving the trustworthiness and performance of these models, and combining different data types will improve usability and reliability of CAD tools for early AD detection in the clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。